MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Medical - Care Facilities

Healthcare
$16.99 +2.63%

+$0.40 today

Market cap
$4.78B
Beta
-3.63
P/E (TTM)
-14.2
EPS (TTM)
-$1.91
52W Low $10.65High $20.48

Volume 4.70M

Average 0.95M

MMED Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

MiniMed Group, Inc. Common StockNASDAQ: MMED

Depreciation & Amortization · Q1 FY2026 · quarter ended Jul 2026

Depreciation & amortization of $41M in Q1 FY2026

Q1 FY2026 depreciation & amortization was $41M. Trailing-twelve-month depreciation & amortization was $158M. Over 3 fiscal years it compounded at +10.7% a year.

Context

  • Depreciation & amortization amounted to 5.0% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly depreciation & amortization holds near $41M or moves back toward the trailing-twelve-month quarterly average of $39.5M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
$41M+5.1% QoQ
Last fiscal yearApr 2026
$156M+9.1% YoY
LTMJul 2026
$158M— YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+9.1%——
3-year CAGR+10.7%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
156M USD
Year-over-year change
+9.1%
3-year CAGR
+10.7%

Depreciation & Amortization vs competitors

How MMED compares with its peers on the latest reported figures

  • MMED's LTM Jul 2026 depreciation & amortization of $158M is the 3rd largest of the 7 companies compared; the peer median is $58.21M.
  • Depreciation & amortization amounts to 4.9% of revenue for MMED, versus a peer median of 3.4%.
MMED Competitors Peer median
Depreciation & Amortization for MMED and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$2.85B -3.4%+3.1%7.6%
DXCMDexCom, Inc.LTM Jun 2026$264.1M +11.9%+17.3%5.3%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$158M —+10.7%4.9%
PODDInsulet CorporationLTM Jun 2026$99.3M +14.4%+12.7%3.3%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$17.11M -1.1%-1.2%1.7%
BBNXBeta Bionics, Inc.LTM Mar 2026$2.94M +26.6%+11.3%2.7%
SENSSenseonics Holdings, Inc.LTM Mar 2026$1.48M +102.1%-54.8%3.6%
MMEDVMiniMed Group, Inc.—— ———
Peer median (excluding MMED) $58.21M+13.1%+7.2%3.4%

Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Apr 2023
FY2023
Apr 2024
FY2024
Apr 2025
FY2025
Apr 2026
Net Income(92M)(107M)(198M)(317M)
Depreciation & Amortization115M129M143M156M
Deferred Income Tax(11M)3M(2M)(54M)
Stock-Based Compensation35M38M41M46M
Change in Working Capital(90M)(74M)122M(166M)
Accounts Receivables(70M)(105M)(66M)(538M)
Inventory(28M)5M(19M)(29M)
Accounts Payables14M(4M)191M41M
Other Working Capital(6M)30M16M360M
Other Non-Cash Items37M52M34M138M
Operating Cash Flow(6M)41M140M(197M)
Capital Expenditures(167M)(148M)(193M)(223M)
Acquisitions (Net)0000
Purchases of Investments(13M)(5M)00
Sales of Investments011M00
Other Investing Activities0(15M)0(10M)
Investing Cash Flow(180M)(157M)(193M)(233M)
Debt Repayment0000
Common Stock Issued000538M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities185M112M10M178M
Financing Cash Flow185M112M10M716M
Effect of Forex Changes0001M
Net Change in Cash(2M)(4M)(43M)287M
Free Cash Flow(173M)(107M)(53M)(420M)

MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Intrinsic Alpha fair value

Locked

Current Price

$16.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.